| Financial Year |
March 31 2023 |
| Monetary Funds |
774,588,094.30 |
| Held-for-trading Financial Assets |
50,520,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
303,008,972.24 |
| Advances to Suppliers |
133,305,028.07 |
| Other Receivables |
56,587,248.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
200,826,292.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
5,299,356.00 |
| Other Current Assets |
54,264,129.88 |
| Total Current Assets |
1,595,131,773.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
17,245,538.38 |
| Fixed Assetes |
472,748,356.28 |
| Under-construction Projects |
3,346,098.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
81,381,048.65 |
| R&D expenses |
-- |
| Goodwill |
8,702,175.89 |
| Long-Term Deferred and Prepaid Expenses |
4,148,663.69 |
| Deferred Income Tax Assets |
61,412,441.37 |
| Other Non-Current Assets |
23,739,831.51 |
| Sub-Total of Non-Current Assets |
676,699,411.24 |
| Total Assets |
2,271,831,184.55 |
| Short-Term Loans |
1,029,024,230.96 |
| Trading Financial liabilities |
-- |
| Notes Payable |
8,350,000.00 |
| Accounts Payable |
80,007,717.03 |
| Accounts Received In Advance |
3,047,090.48 |
| Employee Compensation Payable |
3,425,231.08 |
| Taxes Payable |
9,829,641.61 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
41,557,230.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
50,197,339.05 |
| Other Current Liabilities |
4,921,293.52 |
| Sub-Total of Current Liabilities |
1,255,303,084.59 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
18,989,665.59 |
| Special Payable |
-- |
| Estimatied Liabilities |
3,000,000.00 |
| Deferred Income Tax Liabilities |
11,865,549.37 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
38,061,701.85 |
| Total Liabilities |
1,293,364,786.44 |
| Paid-In Capital(Or Share Stock) |
921,600,000.00 |
| Capital Surplus |
35,256,006.19 |
| Surplus Reserve |
60,774,455.33 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-18,013,071.85 |
| Minority Stockholder's Interest |
-17,875,814.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
996,342,212.99 |
| Owner's Equity（Stockholder's Equity） |
978,466,398.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,271,831,184.55 |
